Patient Demographic Characteristics
high-grade NMIBC
Among 312 patients with high-grade NMIBC (median [IQR] age, 73 [66-79] years; 255 [91.7%] male, 57 [18.3%] female, and 292 [93.6%]) White); 174 received BCG and 138 received gemcitabine and docetaxel (